Liver Fibrosis Staging with Diffusion-Weighted Imaging: a Systematic Review and Meta-Analysis

Hanyu Jiang,Jie Chen,Ronghui Gao,Zixing Huang,Mingpeng Wu,Bin Song

DOI: https://doi.org/10.1007/s00261-016-0913-6

IF: 2.4

2017-01-01

Abdominal Radiology

Abstract:A meta-analysis was performed to assess the diagnostic performance of diffusion-weighted imaging (DWI) in liver fibrosis (LF) staging.

What problem does this paper attempt to address?

Meta-analysis of Hepatic Fibrotic Magnetic Resonance Diffusion Weighted Imaging

马武毅,黄嵘,邓灵波,张凯,张重明,言伟强,成官迅

DOI: https://doi.org/10.3969/j.issn.1672-5131.2017.09.025

2017-01-01

Abstract:Objective A meta-analysis was performed to assess the diagnostic efficiency of DWI (diffusion-weighted imaging) for hepatic fibrosis stage assessment with MR imaging. Methods Online journal databases had been searched. Diagnostic tests of DWI for hepatic fibrosis stage assessment were included. Liver fibrosis was categorized by redistribution into five stages according to the histopathological description by Metavir, Scheuer and Batts-Ludwig score system. The quality of these studies were evaluated according to the QUADAS (Quality assessment of diagnostic accuracy studies) items. The Meta-analysis and the SROC (Summary receiver operating characteristic) curve were performed by Meta-Disc. Results Thirteen studies were identified which met the criteria could perform a meta-analysis. There were 809 cases involved in this study. Meta-analysis showed high heterogeneities among these studies. The pooled sensitivity of G1, G2, G3, G4 hepatic fibrosis stages were 0.74, 0.83, 0.78 and 0.83 respectively. The pooled specificity were 0.74, 0.76, 0.79and 0.79 respectively. The AUCs of SROC were 0.8363, 0.8820, 0.8663 and 0.8719 respectively. Conclusion DWI has a high diagnostic efficiency for staging hepatic fibrosis.
Staging liver fibrosis with various diffusion-weighted magnetic resonance imaging models

Yan-Li Jiang,Juan Li,Peng-Fei Zhang,Feng-Xian Fan,Jie Zou,Pin Yang,Peng-Fei Wang,Shao-Yu Wang,Jing Zhang

DOI: https://doi.org/10.3748/wjg.v30.i9.1164

IF: 5.374

2024-03-07

World Journal of Gastroenterology

Abstract:BACKGROUND Diffusion-weighted imaging (DWI) has been developed to stage liver fibrosis. However, its diagnostic performance is inconsistent among studies. Therefore, it is worth studying the diagnostic value of various diffusion models for liver fibrosis in one cohort. AIM To evaluate the clinical potential of six diffusion-weighted models in liver fibrosis staging and compare their diagnostic performances. METHODS This prospective study enrolled 59 patients suspected of liver disease and scheduled for liver biopsy and 17 healthy participants. All participants underwent multi-b value DWI. The main DWI-derived parameters included Mono-apparent diffusion coefficient (ADC) from mono-exponential DWI, intravoxel incoherent motion model-derived true diffusion coefficient (IVIM-D), diffusion kurtosis imaging-derived apparent diffusivity (DKI-MD), stretched exponential model-derived distributed diffusion coefficient (SEM-DDC), fractional order calculus (FROC) model-derived diffusion coefficient (FROC-D) and FROC model-derived microstructural quantity (FROC-μ), and continuous-time random-walk (CTRW) model-derived anomalous diffusion coefficient (CTRW-D) and CTRW model-derived temporal diffusion heterogeneity index (CTRW-α). The correlations between DWI-derived parameters and fibrosis stages and the parameters’ diagnostic efficacy in detecting significant fibrosis (SF) were assessed and compared. RESULTS CTRW-D (r = -0.356), CTRW-α (r = -0.297), DKI-MD (r = -0.297), FROC-D (r = -0.350), FROC-μ (r = -0.321), IVIM-D (r = -0.251), Mono-ADC (r = -0.362), and SEM-DDC (r = -0.263) were significantly correlated with fibrosis stages. The areas under the ROC curves (AUCs) of the combined index of the six models for distinguishing SF (0.697-0.747) were higher than each of the parameters alone (0.524-0.719). The DWI models’ ability to detect SF was similar. The combined index of CTRW model parameters had the highest AUC (0.747). CONCLUSION The DWI models were similarly valuable in distinguishing SF in patients with liver disease. The combined index of CTRW parameters had the highest AUC.

gastroenterology & hepatology
Diffusion-weighted Imaging and Variable Flip Angle T1 Mapping: a Supplement for Image-Guided Biopsy in Follow-Up Analysis of Liver Fibrosis

Peng Hu,Jihong Sun,Fangfang Lv,Borui Pi,Fangping Xu,Guocan Han,Xi Hu,Yue Wang,Ning Huang,Xia Wu,Xiaoming Yang

DOI: https://doi.org/10.19779/j.cnki.2096-3602.2018.03.04

2018-01-01

Journal of Interventional Medicine

Abstract:Purpose To evaluate the performance of diffusion-weighted imaging (DWI) and variable flip angle (VFA) T1 mapping as a supplement to image-guided biopsy in follow-up analysis of liver fibrosis.Materials and Methods This prospective study was approved by the institution's committee on human research,and written informed consent was provided from the enrolled patients.We investigated five MRI parameters of DWI and VFA T1 mapping,collected from 11 patients who underwent serial ultrasound image-guided biopsy with follow-up MRI within 1.5 years after treatment for liver fibrosis/cirrhosis.For each patient,four consecutive MRI examinations were conducted,including baseline MRI before treatment and three follow-up MRI examinations after treatment at each 0.5-year interval.ADC values at four b values and T1 relaxation times were correlated to pathology-confirmed liver fibrosis stages,which were subsequently divided into two groups,stages F2-3 and F4.The receiver operating characteristic (ROC) analysis and repeated measurement analysis of variance were used for statistical analysis.Results Among these ADC parameters,ADC value (b =500 s/mm2) was the most consistent in differentiating between stage F2-3 and F4 liver fibrosis.Repeated measurement analysis showed that the intra-group and inter-group differences were 0.447 and 0.024,respectively.T1 relaxation time could not consistently differentiate between the F2-3 and F4 groups;however,it was repeatable,and the intra-group and inter-group differences were 0.410 and 0.042,respectively.Conclusion MRI-ADC value at a b value of 500 s/mm2 can be a promising biomarker for differentiating stages F2-3 and F4 liver fibrosis.A combination of this biomarker with repeatable T1 relaxation time may function as a non-invasive tool for follow-up liver fibrosis in patients who reject repeated image-guided biopsy.
[Functional MR Study of Hepatic Fibrosis].

Liu-hong Wang,Min-ming Zhang

DOI: https://doi.org/10.3785/j.issn.1008-9292.2010.02.017

2010-01-01

Abstract:The accurate diagnosis and staging of hepatic fibrosis is crucial for treatment and prognosis of liver disease. The current gold standard is liver biopsy, but it cannot be used in population-based screening, and has well known drawbacks if used for monitoring of disease progression or treatment results. Functional MR, as a non-invasive method, is increasingly used in hepatic fibrosis and became the current hot spot. Most recently available functional MR imaging techniques including diffusion weighted imaging, perfusion weighted imaging and MR spectroscopy can detect cirrhosis or fibrosis reasonably accurately. However, to date only MR elastography has been able to stage fibrosis or diagnose mild disease. MR diffusion weighted appears next most promising.
Feasibility of Diagnosing and Staging Liver Fibrosis with Diffusion Weighted Imaging.

Nai-yi Zhu,Ke-min Chen,Wei-min Chai,Wei-xia Li,Lian-jun Du

DOI: https://doi.org/10.1016/s1001-9294(09)60036-5

2008-01-01

Abstract:OBJECTIVE:To assess the clinical feasibility of diagnosing and staging liver fibrosis by apparent diffusion coefficient (ADC).METHODS:Totally, 43 patients (mean age 29.3 years) with chronic hepatitis by liver biopsy and 7 healthy controls (mean age 39.9 years) underwent liver diffusion weighted imaging (DWI) with four b values: 0, 200, 500, and 1000 s/mm2 respectively. The liver fibrosis was staged according to Ishak fibrosis stage. The ADC value of liver fibrosis patients and healthy controls was compared. The correlation of ADC value and liver fibrosis staging was analyzed.RESULT:The histological staging showed 8 stage 1 patients, 10 stage 2 patients, 6 stage 3 patients, 9 stage 4 patients, 8 stage 5 patients and 2 stage 6 patients. The mean ADC value of liver fibrosis patients was significantly lower than that of healthy controls except for stage 1 group (P < 0.05). There was a negative correlation between liver fibrosis staging and ADC value (r = -0.697 with b=500 s/mm2, P < 0.01). Receiver operating characteristic (ROC) curve of ADC value of advanced liver fibrosis (Ishak stage F3 and higher) showed that area under curve = 0.913, 0.825, and 0.794 with b = 500, 1000, and 200 s/mm2, respectively (95% confidence interval: 83.6%-99.0%, 70.7%-94.3%, 66.5%-92.4%; P < 0.05). When b value was 500 s/mm2, the sensitivity (84%) and specificity (80%) of DWI for diagnosis of advanced liver fibrosis were the highest.CONCLUSION:DWI is proved to be a useful clinical tool in the quantitative evaluation of liver fibrosis and in the prediction of the process of liver fibrosis with the recommendable b value (500 s/mm2).
Monoexponential and advanced diffusion-weighted imaging for hepatic fibrosis staging based on high inter-examiner reliability

Lesheng Huang,Qian Wei,Hui Peng,Wanchun Zhang,Jiahui Tang,Tianzhu Liu

DOI: https://doi.org/10.15537/smj.2024.45.9.20240057

Abstract:Objectives: To determine the diagnostic efficiencies of multiple diffusion-weighted imaging (DWI) techniques for hepatic fibrosis (HF) staging under the premise of high inter-examiner reliability. Methods: Participants with biopsy-confirmed HF were recruited and divided into the early HF (EHF) and advanced HF (AHF) groups; healthy volunteers (HVs) served as controls. Two examiners analyzed intravoxel incoherent motion (IVIM) using the IVIM-DWI and diffusion kurtosis imaging (DKI) models. Intravoxel incoherent motion-DWI, DKI, and diffusion tensor imaging parameters with intraclass correlation coefficients (ICCs) of ≥0.6 were used to create regression models: HVs vs. EHF and EHF vs. AHF. Results: We enrolled 48 HVs, 59 EHF patients, and 38 AHF patients. Mean, radial, and axial kurtosis; fractional anisotropy; mean, radial, and axial diffusivity; and α exhibited excellent reliability (ICCs: 0.80-0.98). Fractional anisotropy of kurtosis, f, and apparent diffusion coefficient showed good reliability (ICCs: 0.69-0.92). The real (0.58-0.67), pseudo- (0.27-0.76), and distributed diffusion coefficients (0.58-0.67) showed low reliability. In the HVs versus (vs.) EHF model, α (p=0.008) and ADC (p=0.011) presented statistical differences (area under curve [AUC]: 0.710). In the EHF vs. AHF model, α (p=0.04) and distributed diffusion coefficient (p=0.02) presented significant differences (AUC: 0.758). Conclusion: Under the premise of high inter-examiner reliability, DWI and IVIM-derived stretched-exponential model parameters may help stage HF.
Recent advances in molecular magnetic resonance imaging of liver fibrosis.

Zhiming Li,Jihong Sun,Xiaoming Yang

DOI: https://doi.org/10.1155/2015/595467

2015-01-01

BioMed Research International

Abstract:Liver fibrosis is a life-threatening disease with high morbidity and mortality owing to its diverse causes. Liver biopsy, as the current gold standard for diagnosing and staging liver fibrosis, has a number of limitations, including sample variability, relatively high cost, an invasive nature, and the potential of complications. Most importantly, in clinical practice, patients often reject additional liver biopsies after initiating treatment despite their being necessary for long-term follow-up. To resolve these problems, a number of different noninvasive imaging-based methods have been developed for accurate diagnosis of liver fibrosis. However, these techniques only reflect morphological or perfusion-related alterations in the liver, and thus they are generally only useful for the diagnosis of late-stage liver fibrosis (liver cirrhosis), which is already characterized by "irreversible" anatomic and hemodynamic changes. Thus, it is essential that new approaches are developed for accurately diagnosing early-stage liver fibrosis as at this stage the disease may be "reversed" by active treatment. The development of molecular MR imaging technology has potential in this regard, as it facilitates noninvasive, target-specific imaging of liver fibrosis. We provide an overview of recent advances in molecular MR imaging for the diagnosis and staging of liver fibrosis and we compare novel technologies with conventional MR imaging techniques.
Value of Intravoxel Incoherent Motion in Detecting and Staging Liver Fibrosis: A Meta-Analysis.

Zheng Ye,Yi Wei,Jie Chen,Shan Yao,Bin Song

DOI: https://doi.org/10.3748/wjg.v26.i23.3304

IF: 5.374

2020-01-01

World Journal of Gastroenterology

Abstract:BACKGROUND Liver fibrosis (LF) is a common pathological feature of all chronic liver diseases. With the accumulation of extracellular matrix in the fibrotic liver, true molecular water diffusion and perfusion-related diffusion are restricted. Intravoxel incoherent motion (IVIM) can capture the information on tissue diffusivity and microcapillary perfusion separately and reflect the fibrotic severity with diffusion coefficients. AIM To investigate the diagnostic performance of IVIM in detecting and staging LF with histology as a reference standard. METHODS A comprehensive literature search was conducted to identify studies on the diagnostic accuracy of IVIM for assessment of histologically proven LF. The stages of LF were classified as F0 (no fibrosis), F1 (portal fibrosis without septa), F2 (periportal fibrosis with few septa), F3 (septal fibrosis), and F4 (cirrhosis) according to histopathological findings. Data were extracted to calculate the pooled sensitivity, specificity, positive and negative likelihood ratios, and diagnostic odds ratio, as well as the area under the summary receiver operating characteristic curve (AUC) in each group. RESULTS A total of 12 studies with 923 subjects were included in this meta-analysis with 5 studies (n = 465) for LF >= F1, 9 studies (n = 757) for LF >= F2, 4 studies (n = 413) for LF >= F3, and 6 studies (n = 562) for LF = F4. The pooled sensitivity and specificity were estimated to be 0.78 (95% confidence interval: 0.73-0.82) and 0.81 (0.74-0.86) for LF >= F1 detection with IVIM; 0.82 (0.79-0.86) and 0.80 (0.75-0.84) for staging F2 fibrosis; 0.85 (0.79-0.90) and 0.83 (0.77-0.87) for staging F3 fibrosis, and 0.90 (0.84-0.94) and 0.75 (0.70-0.79) for detecting F4 cirrhosis, respectively. The AUCs for LF >= F1, F2, F3, F4 detection were 0.862 (0.811-0.914), 0.883 (0.856-0.909), 0.886 (0.865-0.907), and 0.899 (0.866-0.932), respectively. Moderate to substantial heterogeneity was observed with inconsistency index (I-2) ranging from 0% to 77.9%. No publication bias was detected. CONCLUSION IVIM is a noninvasive tool with good diagnostic performance in detecting and staging LF. Optimized and standardized IVIM protocols are needed to further improve its diagnostic accuracy in clinical practice.
A pooled analysis of diffusion-weighted imaging in the diagnosis of hepatocellular carcinoma in chronic liver diseases.

Lian-Ming Wu,Jian-Rong Xu,Qing Lu,Jia Hua,Jie Chen,Jiani Hu

DOI: https://doi.org/10.1111/jgh.12054

2013-01-01

Journal of Gastroenterology and Hepatology

Abstract:Background and Aim The purpose of this study was to perform a meta-analysis of all available studies of the diagnostic performance of diffusion-weighted imaging (DWI) in the detection of hepatocellular carcinoma (HCC) in patients with chronic liver disease. Methods Databases including MEDLINE and EMBASE were searched for relevant original articles published from January 2000 to April 2012. Pooled estimation and subgroup analysis data were obtained by statistical analysis. Results Across the nine studies (476 patients), DWI sensitivity was 81% (95%CI: 67%90%), and specificity was 89% (95% CI: 76%95%). Overall, positive likelihood ratio was 7.11 (95%CI: 3.50, 14.48), negative likelihood ratio was 0.21 (95%CI: 0.120.37), and the diagnostic odds ratio (DOR) was 33.48 (95%CI: 16.6767.25). The area under the curve of the summary receiver operator characteristic (ROC) was 0.92 (95% CI:0.890.94). In studies in which both DWI and conventional contrast-enhanced magnetic resonance imaging (CE-MRI) were performed, the comparison of DWI performance with that of conventional CE-MRI suggested no major differences against these two methods (P?>?0.05). DWI combined CE-MRI had higher pooled sensitivity than DWI alone (93% vs 73%) (P?<?0.05). Conclusion DWI has good diagnostic performance in the detection of HCC in patients with chronic liver disease and equivalent to conventional CE-MRI. Combination of CE-MRI and DWI can improve the diagnostic accuracy of MRI. Further larger prospective studies are still needed to establish its value for detecting HCC in patients with chronic liver disease.
Gadoxetate-disodium-enhanced Magnetic Resonance Imaging for Liver Fibrosis Staging: a Systematic Review and Meta-Analysis

X. Li,H. Liu,R. Wang,J. Yang,Y. Zhang,C. Li

DOI: https://doi.org/10.1016/j.crad.2019.11.001

IF: 3.389

2020-01-01

Clinical Radiology

Abstract:AIM: To identify and evaluate the efficiency of the most commonly used parameters applied to gadoxetate disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI) for liver fibrosis (LF) staging. MATERIALS AND METHODS: Literature searches of PubMed, Web of Science, Embase, and MEDLINE databases from January 2004 to August 2018 were conducted. The applied parameters during imaging were noted and summarised. Studies using the most commonly used parameter were included. Extractive data were combined as pooled weighted mean difference (WMD) to determine the benefits in LF staging. The pooled sensitivity, specificity, and summary receiver operating characteristics (SROC) curve were calculated. RESULTS: Among 57 relevant studies, the contrast enhancement index (CEI) was a relatively commonly used parameter. It was calculated as Sl(post)/Sl(pre), where Sl(post) and Sl(pre) are the liverto-muscle signal intensity ratios in the hepatocyte phase and pre-enhanced images, respectively. Six studies were included. F0 was regarded as normal liver, F1 as mild LF, F2 as moderate LF, and F3 and F4 as advanced LF. Comparisons of WMD revealed significant differences between F1-2 and F3-4. For stage >= F1, the pooled sensitivity, specificity, and areas under SROC curve were 0.58, 0.84, and 0.85, respectively; the corresponding values for >= F2 were 0.57, 0.68, and 0.76, while those for >= F3 were 0.61, 0.75, and 0.72. CONCLUSION: The methodology and parameters used for Gd-EOB-DTPA-enhanced MRI for LF staging are diverse, but the CEI was a relatively common parameter. Overall, there is evidence to support use of CEI, but more evidence from larger studies is needed. (C) 2019 The Royal College of Radiologists. Published by Elsevier Ltd.
Staging of Rat Liver Fibrosis Using Monoexponential, Stretched Exponential and Diffusion Kurtosis Models with Diffusion Weighted Imaging- Magnetic Resonance

Genwen Hu,Wen Liang,Mingxiang Wu,Queenie Chan,Yufa Li,Jianmin Xu,Liangping Luo,Xianyue Quan

DOI: https://doi.org/10.18632/oncotarget.23413

2018-01-01

Oncotarget

Abstract:Early diagnosis of liver fibrosis is important. The objective of this study was to explore the characteristics and to assess the accuracy of monoexponential, stretched exponential models (SEM), and diffusion kurtosis imaging (DKI) with diffusion-weighted imaging (DWI)-magnetic resonance imaging (MRI) in various stages of liver fibrosis in two standard rat models induced by carbon tetrachloride (CCl4) and biliary duct ligation (BDL). Parameters (ADC, Dapp, Kapp, DDC, α) were measured with a 3.0T MRI. Liver fibrosis stages (F0-F4) were defined by METAVIR scoring. Parameters (ADC, Dapp, DDC) were found to be negatively associated (r: -0.675~-0.789; P<0.05) with advancement of fibrosis stage. The analysis of receiver operating characteristic (ROC) curves illustrated that the areas under the curves (AUC) for ADC, Dapp, and DDC were 0.687~0.957, 0.805~0.938 and 0.876~1.000, respectively. The study showed that (ADC, Dapp, Kapp, DDC, α) from various diffusion models reflected pathological and physiological tissue changes. We conclude that SEM and DKI may provide more accurate information about diffusion, and non-Gaussian diffusion analysis may be a complementary tool for the assessment of liver fibrosis.
Comparative Study on Clinical and Pathological Changes of Liver Fibrosis with Diffusion-Weighted Imaging

Mei-Ling Zhou,Fu-Hua Yan,Peng-Ju Xu,Cai-Zhong Chen,Ji-Zhang Shen,Ren-Chen Li,Yuan Ji,Jian-Ying Shi

DOI: https://doi.org/10.3760/cma.j.issn.0376-2491.2009.25.010

2009-01-01

Abstract:OBJECTIVE:To evaluate the clinical practical value of apparent diffusion coefficient (ADC) measurements based on diffusion-weighted MR imaging (DWI) for quantification of liver fibrosis and inflammation for hepatitis viral infection. METHODS:Diffusion-weighted MRI with parallel imaging was prospectively performed on 85 patients with chronic hepatitis and on 22 healthy volunteers within a single breath-hold using a single-shot spin-echo echo-planar sequence at b values of 100, 300, 500, 800 and 1000 s/mm2 respectively. ADC values of liver were measured with five different b values. The inflammation grades and fibrosis stages were evaluated histologically by biopsy. One-way analysis of variance and Spearman' s rank correlation test were used for statistical analysis. Receiver operating characteristics analysis was used to assess the performance of ADC in predicting the presence of stage > or = 2 and stage > or = 3 hepatic fibrosis, and grade > or = 1 hepatic inflammation. RESULTS:There was moderate negative correlation between hepatic ADC values and fibrosis stage. And the best correlation was obtained for a b value of 800 s/mm2 (r = -0.697, P = 0. 000). At all b values there was a significant decrease in hepatic ADC in patients with stage < or = 1 versus stage > or = 2 fibrosis and stage < or = 2 versus stage > or = 3 fibrosis (P < 0.05). Hepatic ADC was a significant predictor of stage > or = 2 and > or = 3 fibrosis. The areas under the curve were 0.909 vs 0.917, sensitivity 76.6% vs 80.0% and specificity 88.3% vs 91.5% (ADC with a b value of 800 s/mm2, 1.26 x 10(-3) mm2/s or less and 1.19 x 10(-3) mm2/s or less). There was weak to moderate negative correlation between ADCs and inflammation grade. Hepatic ADC was a significant predictor of grade > 1 inflammation with an area under the curve of 0.781, sensitivity of 60.0% and specificity of 86.4% (ADC with a b value of 500 s/mm2, 1.54 x 10(-3) mm2/s or less). CONCLUSION:The DWI measurement of hepatic ADC can be used to quantify liver fibrosis and inflammation. It will be a new approach for early diagnosis and therapeutic follow-up of hepatic fibrosis.
Staging Liver Fibrosis with DWI: is There an Added Value for Diffusion Kurtosis Imaging?

Li Yang,Shengxiang Rao,Wentao Wang,Caizhong Chen,Ying Ding,Chun Yang,Robert Grimm,Xu Yan,Caixia Fu,Mengsu Zeng

DOI: https://doi.org/10.1007/s00330-017-5245-6

IF: 7.034

2018-01-01

European Radiology

Abstract:OBJECTIVES:To assess liver fibrosis in patients with chronic liver disease using diffusion kurtosis imaging (DKI) in comparison with conventional diffusion-weighted imaging, with histology as reference standard. METHODS:This prospective study included 81 patients and DKI with b-values of 0, 200, 500, 1,000, 1,500, 2,000 s/mm2 were performed. Mean diffusivity (MD), mean kurtosis (MK) and apparent diffusion coefficient (ADC) maps were calculated. The diagnostic efficacy of MD, MK and ADC for predicting stage 2 fibrosis or greater, and stage 3 fibrosis or greater were compared. RESULTS:The MD (rho=-0.491, p<0.001), MK (rho=0.537, p<0.001) and ADC (rho=-0.496, p<0.001) correlated significantly with fibrosis stages, and ADC exhibited a strong negative correlation with MK (rho=-0.968; p<0.001) and a moderate association with MD (rho=0.601, p<0.001). Areas under the curves (AUCs) for predicting stage 2 fibrosis or greater were not significantly different (p>0.05) between MK (0.809) and ADC (0.797) as well as between MD (0.715) and ADC. AUCs were also similar for MD (0.710), MK (0.768) and ADC (0.747) for predicting stage 3 fibrosis or greater. CONCLUSION:Although DKI is feasible for predicting liver fibrosis in patients with chronic liver disease, MD and MK offer similar diagnostic performance to ADC values. KEY POINTS:• Diffusion kurtosis imaging is feasible for staging liver fibrosis. • Diffusion kurtosis and monoexponential model are highly correlated. • The kurtosis model offers no added value to the conventional, monoexponential model.
Staging Chronic Hepatitis B Related Liver Fibrosis with Diffusion-weighted MRI-based Virtual Elastography: Comparisons with Serum Fibrosis Indexes

Li Yang,Guofeng Zhou,Liheng Liu,Shengxiang Rao,Wentao Wang,Kaipu Jin,Fei Wu,Caixia Fu,Mengsu Zeng,Ying Ding

DOI: https://doi.org/10.1016/j.crad.2024.106750

IF: 3.389

2024-01-01

Clinical Radiology

Abstract:Objectives To evaluate and compare the diagnostic performance of diffusion weighted imaging (DWI)-based virtual MR elastography and serum fibrosis indexes for staging liver fibrosis in patients with chronic hepatitis B (CHB). Methods This retrospective study included 145 patients with CHB. Virtual shear modulus (μDiff) was derived from DWI acquisition with b-values of 200, 1,500/mm2. Aspartate aminotransferase to platelet ratio index (APRI), fibrosis-4 index (FIB-4), S index, Fibro Q and gamma-glutamyl transpeptidase to platelet ratio (GPR) were calculated. The diagnostic efficacy of μDiff and serum indexes for staging liver fibrosis were compared. Results μDiff, APRI, FIB-4, S index, Fibro Q, and GPR increased as the hepatic fibrosis progressed (r=0.23-0.52, P<0.05). Areas under the curves (AUCs) of μDiff were 0.725, 0.817 and 0.764 for significant fibrosis, advanced fibrosis, and cirrhosis, respectively. μDiff had greater AUC over FIB-4 (0.686) and Fibro Q (0.638) for advanced fibrosis (P<0.05). The AUCs of combination of μDiff with APRI, FIB-4, S index, Fibro Q, and GPR individually were 0.779, 0.772, 0.763, 0.728, 0.756 for significant fibrosis, 0.856, 0.842, 0.834, 0.831, 0.834 for advanced fibrosis, 0.811, 0.818, 0.784, 0.835, 0.788 for cirrhosis, respectively. The AUCs of the combinations were significantly higher than individual serum index for advanced fibrosis and cirrhosis (all P<0.05). Conclusion DWI-based virtual MR elastography could estimate liver fibrosis stages in patients with CHB, which outperformed FIB-4 and Fibro Q for advanced fibrosis. The combination of μDiff with each serum index appears superior to individual serum index for advanced fibrosis and cirrhosis.
Role of radiomics in staging liver fibrosis: a meta-analysis

Xiao-min Wang,Xiao-jing Zhang

DOI: https://doi.org/10.1186/s12880-024-01272-x

IF: 2.7949

2024-04-13

BMC Medical Imaging

Abstract:Fibrosis has important pathoetiological and prognostic roles in chronic liver disease. This study evaluates the role of radiomics in staging liver fibrosis.

radiology, nuclear medicine & medical imaging
Staging liver fibrosis by a continuous-time random-walk diffusion model

Yanli Jiang,Fengxian Fan,Pengfei Zhang,Jun Wang,Wenjing Huang,Yu Zheng,Ruiqing Guo,Shaoyu Wang,Jing Zhang

DOI: https://doi.org/10.1016/j.mri.2023.11.009

IF: 3.13

2023-11-13

Magnetic Resonance Imaging

Abstract:Purpose Noninvasive assessment of liver fibrosis holds significant clinical importance. We aimed to evaluate the clinical potential of using a continuous-time random-walk diffusion model (CTRW) for staging liver fibrosis. Methods This prospective study included 52 patients suspected of liver disease and scheduled for liver biopsy. All patients underwent multi-b value diffusion-weighted imaging (DWI) using a 1.5 T MR scanner to derive the anomalous diffusion coefficient (D) and temporal (α) and spatial (β) diffusion heterogeneity indexes sourced from the CTRW. The mono-exponential DWI-derived apparent diffusion coefficient (ADC), transient elastography-derived liver stiffness measurement (LSM), aspartate aminotransferase-to-platelet ratio index (APRI), and fibrosis-4 (FIB-4) index were calculated. We assessed and compared the correlations of these parameters with fibrosis stages and their efficacy in staging liver fibrosis. Results Significant correlations with fibrosis stages were found for APRI ( r = 0.336), FIB-4 ( r = 0.351), LSM ( r = 0.523), D ( r = −0.458), and ADC ( r = −0.473). Significant differences were observed between APRI, LSM, D, and ADC of different fibrosis stages. The diagnostic performance of an index that combined D, α, β, ADC, and LSM was superior to that of ADC or LSM alone for fibrosis stage F ≥ 2 and better than the index that combined D, α, β for fibrosis stage F ≥ 4. Conclusions Accurate liver fibrosis staging was achieved with a model that combined CTRW-derived parameters (D, α, and β), ADC, and LSM. The model could serve as a reliable tool for noninvasive fibrosis evaluation.

radiology, nuclear medicine & medical imaging
Quantitative Assessment of Liver Fibrosis and Its Stage in a Rabbit Model by Using Intravoxel Incoherent Motion Diffusion-Weighted Imaging at a 3T Magnetic Resonance System

Fan Chen,Jian-Qiong Yang,Xiao-Ming Zhang,Rui Li,Tian-Wu Chen,Yan-Li Chen,Yu Jiang,Lan Wu

DOI: https://doi.org/10.21037/tcr.2017.10.34

2017-01-01

Translational Cancer Research

Abstract:Background: To explore whether and how intravoxel incoherent motion (IVIM) diffusion-weighted imaging (DWI) at a 3T magnetic resonance scanner could monitor and stage liver fibrosis in a rabbit model. Methods: Fifty-six New Zealand white rabbits were given carbon tetrachloride to model liver fibrosis, and eight treated with normal saline served as control subjects. IVIM-DWI with eight b values of 0, 10, 20, 50, 100, 200, 800, 1,000 s/mm2 was performed on the 0, 6 th , 8 th , 10 th and 12 th weekends after modeling this disease. The stages of liver fibrosis (stages F0 to F4) were identified based on METAVIR classification system. The IVIM derived parameters (D*, pseudo-diffusion; D, pure molecular diffusion; and f, perfusion fraction) were quantitatively measured, and statistical analysis were performed for detecting and staging liver fibrosis. Results: Significant difference was found in D between normal and fibrotic liver (P 0.05). A negative correlation was found between fibrosis stage and D (r=−0.605, P Conclusions: The IVIM derived parameter D can quantitatively monitor the progression of liver fibrosis.
Aassessment of diffusion-weighted imaging in staging liver ifbrosis in rabbits

DENG Qian-hua,RUAN Ji-yin,JIANG Jin-zhao,FENG Fei,XIE Jia-jun,ZOU Li-qiu

DOI: https://doi.org/10.3969/j.issn.1674-8034.2015.06.014

2015-01-01

Abstract:Objective: To evaluate the accuracy of apparent diffusion coefifcient(ADC) correlates on staging liver ifbrosis.Materials and Methods:The study consisted of three groups: HF group (n=32), control group (n=15) and supplemental group (n=12). Rabbits from control and HF group underwent conventional MRI and DWI scan and the liver ADC values were measured. In HF group, eight rabbits randomly underwent MRI examinations at 4, 5, 6, 10 weeks after CCl4 administration. The correlation between ADC values and HF stages was assessed. The diagnostic performance of DWI for staging HF was compared using the receiver operating characteristic curve analysis on the basis of the histopathologic analysis of HF.Results:Signiifcant differences of ADC values were present among HF stages (F=5.344,P<0.005). The ADC values were correlated with the HF stages (r=-0.630,P<0.001). Sensitivity, specificity, positive (PPV) and negative predictive values (NPV) were for≥S1: 75.00%, 55.56%, 85.70%, 38.50%, respectively; for≥S2: 79.2%, 58.8%, 73.1%, 66.7%; for≥S3: 87.5%, 80.0%, 73.70%, 90.9%; for S4: 87.50%, 66.67%, 38.90%, 95.7%.Conclusion:DWI can offer important assistance in staging HF as a non-invasive technique.
Differential Diagnosis Between Hepatic Metastases and Benign Focal Lesions Using DWI with Parallel Acquisition Technique: a Meta-Analysis

Chenggang Wei,Jieying Tan,Li Xu,Liu Juan,Si Wei Zhang,Lu Wang,Qun Wang

DOI: https://doi.org/10.1007/s13277-014-2663-9

2014-01-01

Tumor Biology

Abstract:We aim to investigate the diagnostic capability of diffusion-weighted imaging using parallel acquisition technique for the differentiation between hepatic metastases and benign focal lesions with a meta-analysis. The meta-analysis included a total of 858 hepatic metastases and 440 benign liver lesions from nine studies. The pooled sensitivity and specificity of diffusion-weighted imaging (DWI) were 0.87 (95 % CI, 0.84–0.89) and 0.90 (95 % CI, 0.87–0.93), respectively. The positive likelihood ratio (PLR) and negative likelihood ratio (NLR) were 8.50 (95 % CI, 4.97–14.52) and 0.17 (95 % CI, 0.11–0.26), respectively. The P value for χ 2 heterogeneity for all pooled estimates was <0.05. From the fitted summary receiver operating characteristics (SROC), the area under the curve (AUC) and Q* index were 0.95 and 0.88, respectively. Publication bias is not present (t = −0.76, P = 0.471). The meta-regression analysis indicated that evaluated covariates included patient number, patient population, mean age, maximum of b factor, number of cysts, number of hemangiomas, and field were not sources of heterogeneity (all P value >0.05). Diffusion-weighted imaging was useful for differentiation between hepatic metastases and benign focal lesions. The diffusion characteristics of the benign hepatocellular lesions, including cases of focal nodular hyperplasia (FNH) and adenoma, have rarely been reported and need further studies. The diagnostic capability of DWI with parallel acquisition technique for differentiation between metastases and benign hepatic focal lesions might be overestimated.
Comparison and optimization of b value combinations for diffusion-weighted imaging in discriminating hepatic fibrosis

Jiaoyan Wang,Xue Zhou,Mingrong Yao,Wenli Tan,Songhua Zhan,Kun Liu,Zhen Feng,Huamei Yan,Yongming Dai,Jie Yuan

DOI: https://doi.org/10.1007/s00261-023-04159-7

IF: 2.4

2024-01-30

Abdominal Radiology

Abstract:Diffusion-weighted imaging (DWI) has shown potential in characterizing hepatic fibrosis. However, there are no widely accepted apparent diffusion coefficient (ADC) values for the b value combination. This study aims to determine the optimal high and low b values of DWI to assess hepatic fibrosis in patients with chronic liver disease.

radiology, nuclear medicine & medical imaging

Liver Fibrosis Staging with Diffusion-Weighted Imaging: a Systematic Review and Meta-Analysis

Meta-analysis of Hepatic Fibrotic Magnetic Resonance Diffusion Weighted Imaging

Staging liver fibrosis with various diffusion-weighted magnetic resonance imaging models

Diffusion-weighted Imaging and Variable Flip Angle T1 Mapping: a Supplement for Image-Guided Biopsy in Follow-Up Analysis of Liver Fibrosis

[Functional MR Study of Hepatic Fibrosis].

Feasibility of Diagnosing and Staging Liver Fibrosis with Diffusion Weighted Imaging.

Monoexponential and advanced diffusion-weighted imaging for hepatic fibrosis staging based on high inter-examiner reliability

Recent advances in molecular magnetic resonance imaging of liver fibrosis.

Value of Intravoxel Incoherent Motion in Detecting and Staging Liver Fibrosis: A Meta-Analysis.

A pooled analysis of diffusion-weighted imaging in the diagnosis of hepatocellular carcinoma in chronic liver diseases.

Gadoxetate-disodium-enhanced Magnetic Resonance Imaging for Liver Fibrosis Staging: a Systematic Review and Meta-Analysis

Staging of Rat Liver Fibrosis Using Monoexponential, Stretched Exponential and Diffusion Kurtosis Models with Diffusion Weighted Imaging- Magnetic Resonance

Comparative Study on Clinical and Pathological Changes of Liver Fibrosis with Diffusion-Weighted Imaging

Staging Liver Fibrosis with DWI: is There an Added Value for Diffusion Kurtosis Imaging?

Staging Chronic Hepatitis B Related Liver Fibrosis with Diffusion-weighted MRI-based Virtual Elastography: Comparisons with Serum Fibrosis Indexes

Role of radiomics in staging liver fibrosis: a meta-analysis

Staging liver fibrosis by a continuous-time random-walk diffusion model

Quantitative Assessment of Liver Fibrosis and Its Stage in a Rabbit Model by Using Intravoxel Incoherent Motion Diffusion-Weighted Imaging at a 3T Magnetic Resonance System

Aassessment of diffusion-weighted imaging in staging liver ifbrosis in rabbits

Differential Diagnosis Between Hepatic Metastases and Benign Focal Lesions Using DWI with Parallel Acquisition Technique: a Meta-Analysis

Comparison and optimization of b value combinations for diffusion-weighted imaging in discriminating hepatic fibrosis